Another Study Shows That Truvada Is Incredibly Effective

Expanding the LGBTQ Conversation
July 22 2014 8:42 AM

Yet Another Study Proves It: Truvada Is Incredibly Effective

Par7072595
Miracle drug.

Photo by JOEL SAGET/AFP/GettyImages

The results of a massive, years-long, worldwide study on HIV-preventing drugs (PrEP) are in, and the news is great: PrEP is highly effective, extremely safe, and unlikely to lead to a drop in condom usage.

The new study, called iPrEx OLE, reinforces two important—and frequently challenged—facts about PrEP. First, not a single participant in the study who took PrEP four to seven times a week contracted HIV. (The drug is meant to be taken once daily.) Taking PrEP only two to three times a week still resulted in a 90 percent reduced risk of HIV acquisition. Taken together, these figures suggest that PrEP truly does reach near-perfect levels of effectiveness when taken as prescribed.

Advertisement

Second, the study found absolutely no “sexual risk compensation” among participants—that is, those taking PrEP did not abandon other forms of protection, namely condoms. That data was self-reported. But researchers also tested participants for syphilis, another marker of sexually risky behavior, and found that those on PrEP were no more likely to carry the sexually transmitted infection than those not taking the drug. These data buttress the increasingly conventional wisdom that those responsible enough to take PrEP are also responsible enough to use condoms.

None of this should come as a surprise if you’ve been following the medical world’s sudden embrace of PrEP, sold in the United States as Truvada. The Centers for Disease Control and the World Health Organization have boldly endorsed PrEP to be used alongside condoms, particularly for men who have sex with men. New York governor Andrew Cuomo has also endorsed the drug as part of his broader AIDS eradication plan. The LGBTQ community itself may still be grappling with the implications of PrEP, but the science is clear: This drug is the future of HIV prevention. 

Mark Joseph Stern is a writer for Slate. He covers science, the law, and LGBTQ issues.

TODAY IN SLATE

Medical Examiner

Here’s Where We Stand With Ebola

Even experienced international disaster responders are shocked at how bad it’s gotten.

It’s Legal for Obama to Bomb Syria Because He Says It Is

Divestment Is Fine but Mostly Symbolic. There’s a Better Way for Universities to Fight Climate Change.

I Stand With Emma Watson on Women’s Rights

Even though I know I’m going to get flak for it.

It Is Very Stupid to Compare Hope Solo to Ray Rice

Building a Better Workplace

In Defense of HR

Startups and small businesses shouldn’t skip over a human resources department.

Why Are Lighter-Skinned Latinos and Asians More Likely to Vote Republican?

How Ted Cruz and Scott Brown Misunderstand What It Means to Be an American Citizen

  News & Politics
Politics
Sept. 23 2014 12:43 PM Occupy Wall Street How can Hillary Clinton be both a limousine liberal and a Saul Alinsky radical?
  Business
Moneybox
Sept. 23 2014 2:08 PM Home Depot’s Former Head of Security Had a Legacy of Sabotage
  Life
Outward
Sept. 23 2014 1:57 PM Would A Second Sarkozy Presidency End Marriage Equality in France?
  Double X
The XX Factor
Sept. 23 2014 2:32 PM Politico Asks: Why Is Gabby Giffords So “Ruthless” on Gun Control?
  Slate Plus
Slate Plus
Sept. 22 2014 1:52 PM Tell Us What You Think About Slate Plus Help us improve our new membership program.
  Arts
Brow Beat
Sept. 23 2014 2:31 PM 3 Simpsons Showrunners Reflect on New Fans and the “Classic Era” Myth
  Technology
Future Tense
Sept. 23 2014 1:50 PM Oh, the Futility! Frogs Try to Catch Worms Off of an iPhone Video.
  Health & Science
Science
Sept. 23 2014 1:38 PM Why Is Fall Red in America but Yellow in Europe? A possible explanation, 35 million years in the making.
  Sports
Sports Nut
Sept. 18 2014 11:42 AM Grandmaster Clash One of the most amazing feats in chess history just happened, and no one noticed.